Brain signal ID’s responders to fast-acting antidepressant

Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant. The brain signal, detectable by noninvasive imaging, also holds clues to the agent’s underlying mechanism, which are vital for drug development, say National Institutes of Health researchers.

Read more View All News

This page was last updated on Friday, January 21, 2022